Alzheimer's disease P Scheltens, B De Strooper, M Kivipelto, H Holstege, G Chételat, ... The Lancet 397 (10284), 1577-1590, 2021 | 3366 | 2021 |
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ... Alzheimer's & dementia 10 (6), 844-852, 2014 | 2874 | 2014 |
Alzheimer disease DS Knopman, H Amieva, RC Petersen, G Chételat, DM Holtzman, ... Nature reviews Disease primers 7 (1), 33, 2021 | 1820 | 2021 |
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1680 | 2015 |
Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance Y Stern, EM Arenaza‐Urquijo, D Bartrés‐Faz, S Belleville, M Cantilon, ... Alzheimer's & Dementia 16 (9), 1305-1311, 2020 | 1329 | 2020 |
Brain charts for the human lifespan RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ... Nature 604 (7906), 525-533, 2022 | 1096 | 2022 |
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 1041 | 2011 |
In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease JC Baron, G Chételat, B Desgranges, G Perchey, B Landeau, ... Neuroimage 14 (2), 298-309, 2001 | 836 | 2001 |
Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? G Chetelat, B Desgranges, V De La Sayette, F Viader, F Eustache, ... Neurology 60 (8), 1374-1377, 2003 | 742 | 2003 |
Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study G Chételat, B Landeau, F Eustache, F Mézenge, F Viader, ... Neuroimage 27 (4), 934-946, 2005 | 685 | 2005 |
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 677 | 2015 |
Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging E Gerardin, G Chételat, M Chupin, R Cuingnet, B Desgranges, HS Kim, ... Neuroimage 47 (4), 1476-1486, 2009 | 535 | 2009 |
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ... Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015 | 495 | 2015 |
Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging G Kalpouzos, G Chételat, JC Baron, B Landeau, K Mevel, C Godeau, ... Neurobiology of aging 30 (1), 112-124, 2009 | 476 | 2009 |
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease N Villain, B Desgranges, F Viader, V De La Sayette, F Mézenge, ... Journal of Neuroscience 28 (24), 6174-6181, 2008 | 463 | 2008 |
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 462 | 2010 |
International Society to Advance Alzheimer’s Research and Treatment, Alzheimer’s Association GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ... Perspectives on ethnic and racial disparities in Alzheimer’s disease and …, 2019 | 451 | 2019 |
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias G Chételat, J Arbizu, H Barthel, V Garibotto, I Law, S Morbelli, ... The Lancet Neurology 19 (11), 951-962, 2020 | 448 | 2020 |
Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment G Chételat, B Desgranges, V De La Sayette, F Viader, F Eustache, ... Neuroreport 13 (15), 1939-1943, 2002 | 447 | 2002 |
Why musical memory can be preserved in advanced Alzheimer’s disease JH Jacobsen, J Stelzer, TH Fritz, G Chételat, R La Joie, R Turner Brain 138 (8), 2438-2450, 2015 | 443 | 2015 |